A Study to Investigate the Safety, Tolerability, and Preliminary Efficacy With AION-301 Administered by Intravenous Infusion Compared With Placebo Administered by Intravenous Infusion Investigational Intervention in Participants Aged 35 to 75 Years of Age With Chronic Kidney Disease (CKD)
Clinical trial NCT06721143 · RECRUITING
Trial details
- NCT number
- NCT06721143
- Sponsor
- AION Healthspan, Inc.
- Status
- RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2025-01-23
- Primary completion
- 2027-01-01
- Enrollment
- 36
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.